BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression Profiles of Breast Tumors from Singapore and Europe

Dataset: Expression Profiles of Breast Tumors from Singapore and Europe

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that...

Registered by ArrayExpress Uploader
View Dataset

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. al., Genome Biology, 2013. While the majority of the tumor expression profiles included in this database derived from publicly accessible microarray repositories, a number of the samples had not been previously published. Here, we describe the origin of these samples and provide their associated clinical and pathological annotations with the hope that other investigators will be able to utilize these data in their own research. Breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore) were profiled on the Affymetrix U133A platform. The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Species:
human

Samples:
139

Source:
E-GEOD-45255

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample DMFS TIME DFS EVENT DEFINED AS ANY TYPE OF RECURRENCE OR DEATH FROM BREAST CANCER CHARACTERISTICS HISTOLOGICAL GRADE SIZE MM LN STATUS TREATMENT TYPE DFS TIME PATIENT AGE DMFS EVENT DEFINED AS DISTANT METASTASIS OR DEATH FROM BREAST CANCER PGR STATUS HISTOLOGY YES DSS EVENT DEFINED AS DEATH FROM BREAST CANCER ER STATUS HER2 STATUS DSS TIME
GSM1100175 9.419 not specified endocrine? (0=no, 1=yes): 0 G1 21 LN- none 9.42 43 not specified NA NA not specified NA ER+ NA NA
GSM1100174 10.614 1 endocrine? (0=no, 1=yes): 0 G2 23 LN- none 10.61 37 not specified NA NA not specified NA ER- NA NA
GSM1100173 7.151 1 endocrine? (0=no, 1=yes): 0 NA 10 LN- none 7.15 67 1 NA NA not specified NA ER- NA NA
GSM1100172 1.66 NA endocrine? (0=no, 1=yes): 0 G3 29 LN- CMFx6 NA 50 not specified PgR- NA 1 not specified ER- He- 1.66027397260274
GSM110017 4.51 NA endocrine? (0=no, 1=yes): 1 G2 20 LN- tamoxifen NA 72 not specified PgR- NA 1 not specified ER+ He- 4.50958904109589
GSM1100170 3.93 NA endocrine? (0=no, 1=yes): 1 G1 30 LN- tamoxifen NA 56 not specified PgR+ NA 1 not specified ER+ He+ 3.92602739726027
GSM1100169 4.96 NA endocrine? (0=no, 1=yes): 1 G3 27 LN- CMFx6; Tamoxifen NA 46 not specified PgR- NA 1 not specified ER- He- 4.95890410958904
GSM1100168 4.56 NA endocrine? (0=no, 1=yes): 1 G2 30 LN- tamoxifen NA 45 not specified PgR+ NA 1 not specified ER+ He+ 4.56164383561644
GSM1100167 5.01 NA endocrine? (0=no, 1=yes): 0 G3 60 LN- CMFx6 NA 48 not specified PgR- NA 1 not specified ER- He+ 5.00821917808219
GSM1100166 4.64 NA endocrine? (0=no, 1=yes): 0 G2 20 LN- CMFx6 NA 45 not specified PgR+ NA 1 not specified ER+ He- 4.64383561643836
GSM1100165 5.13 NA endocrine? (0=no, 1=yes): 1 G2 20 LN- tamoxifen NA 70 not specified PgR- NA 1 not specified ER+ He- 5.13424657534247
GSM1100164 6.26 NA endocrine? (0=no, 1=yes): 0 G3 45 LN- ACx4 NA 59 not specified PgR- NA 1 not specified ER- NA 6.25753424657534
GSM1100163 5.57 NA endocrine? (0=no, 1=yes): 1 G3 14 LN- CMFx6; Arimidex/Tamoxifen NA 61 not specified PgR- NA 1 not specified ER- He- 5.56712328767123
GSM1100162 5.11 NA endocrine? (0=no, 1=yes): 1 G3 20 LN- ACx4; Arimidex/Tamoxifen NA 60 not specified PgR+ NA 1 not specified ER+ He- 5.10958904109589
GSM110016 5.52 NA endocrine? (0=no, 1=yes): 1 G3 19 LN- tamoxifen NA 53 not specified PgR+ NA 1 not specified ER+ He- 5.52328767123288
GSM1100160 6.69 NA endocrine? (0=no, 1=yes): 0 G2 14 LN- CMFx6 NA 42 not specified PgR+ NA 1 not specified ER+ He- 6.69315068493151
GSM1100159 6.19 NA endocrine? (0=no, 1=yes): NA NA 38 LN- NA NA 73 not specified PgR- NA NA not specified ER- He- 6.18630136986301
GSM1100158 2.57 NA endocrine? (0=no, 1=yes): 1 G3 32 LN- CMFx6; Tamoxifen NA 46 not specified NA NA 1 not specified NA NA 2.57260273972603
GSM1100157 3.12 NA endocrine? (0=no, 1=yes): 1 G1 20 LN- tamoxifen NA 57 not specified PgR- NA 1 not specified ER+ He+ 3.11506849315069
GSM1100156 5.94 NA endocrine? (0=no, 1=yes): 1 G1 27 LN- tamoxifen NA 66 not specified PgR+ NA 1 not specified ER+ He- 5.93698630136986
GSM1100155 6.13 NA endocrine? (0=no, 1=yes): 1 G3 27 LN- tamoxifen NA 62 not specified PgR+ NA 1 not specified ER+ He+ 6.12876712328767
GSM1100154 6.61 NA endocrine? (0=no, 1=yes): 1 G3 40 LN- ACx6; Tamoxifen NA 67 not specified PgR- NA 1 not specified ER- He- 6.61369863013699
GSM1100153 6.65 NA endocrine? (0=no, 1=yes): 1 G2 35 LN- tamoxifen NA 70 not specified PgR- NA 1 not specified ER+ He+ 6.65205479452055
GSM1100152 6.18 NA endocrine? (0=no, 1=yes): 1 G2 15 LN- tamoxifen NA 77 not specified PgR+ NA 1 not specified ER+ He+ 6.17534246575342
GSM110015 6.02 NA endocrine? (0=no, 1=yes): 1 G2 20 LN- ACx4; Tamoxifen NA 52 not specified PgR- NA 1 not specified ER- He+ 6.01917808219178
GSM1100150 7.57 NA endocrine? (0=no, 1=yes): 1 G2 20 LN- tamoxifen NA 81 not specified PgR- NA 1 not specified ER+ He+ 7.57260273972603
GSM1100149 7.31 NA endocrine? (0=no, 1=yes): 1 G3 18 LN- tamoxifen NA 55 not specified PgR+ NA 1 not specified ER+ He- 7.30684931506849
GSM1100148 7.85 NA endocrine? (0=no, 1=yes): 1 G2 12 LN- Tamoxifen+Zoledronic acid NA 48 not specified NA NA 1 not specified ER+ He+ 7.85479452054795
GSM1100147 7.82 NA endocrine? (0=no, 1=yes): 1 G2 10 LN- tamoxifen NA 54 not specified PgR- NA 1 not specified ER- He- 7.82191780821918
GSM1100146 3.30 NA endocrine? (0=no, 1=yes): 1 G3 37 LN- Arimidex/Tamoxifen NA 72 1 PgR+ NA 1 not specified ER+ He+ 5.16438356164384
GSM1100145 3.65 NA endocrine? (0=no, 1=yes): 1 G3 40 LN- CMFx2; Tamoxifen NA 60 1 PgR+ NA 1 not specified ER+ He- 6.75068493150685
GSM1100144 6.15 NA endocrine? (0=no, 1=yes): 0 G1 55 LN- ACx4 NA 54 1 PgR- NA 1 not specified ER+ He- 8.02191780821918
GSM1100143 2.42 NA endocrine? (0=no, 1=yes): 1 G2 13 LN- Tamoxifen+Zoledronic acid NA 36 1 PgR- NA 1 not specified ER- He- 7.07945205479452
GSM1100142 2.18 NA endocrine? (0=no, 1=yes): 1 G1 10 LN- Tamoxifen+Zoledronic acid NA 46 not specified PgR- NA 1 not specified ER+ He- 2.18904109589041
GSM110014 0.76 NA endocrine? (0=no, 1=yes): 1 G3 35 LN- tamoxifen NA 70 1 PgR+ NA 1 1 ER+ He+ 0.991780821917808
GSM1100140 3.80 NA endocrine? (0=no, 1=yes): 0 G3 34 LN- ACx3/CMFx1 NA 73 1 PgR- NA 1 1 ER- He- 4.62191780821918
GSM1100139 2.21 NA endocrine? (0=no, 1=yes): 1 G3 46 LN- tamoxifen NA 63 1 PgR+ NA 1 1 ER+ He- 4.92876712328767
GSM1100138 1.35 NA endocrine? (0=no, 1=yes): 1 G3 32 LN- ECx4; Tamoxifen NA 38 1 PgR- NA 1 1 ER+ He- 2.75342465753425
GSM1100137 0.25 NA endocrine? (0=no, 1=yes): 1 NA 85 LN- tamoxifen NA 57 1 PgR+ NA 1 1 ER+ He+ 5.03561643835616
GSM1100136 4.51 NA endocrine? (0=no, 1=yes): 1 G3 17 LN- tamoxifen NA 68 1 PgR+ NA 1 1 ER+ He- 6.17260273972603
GSM1100135 4.18 NA endocrine? (0=no, 1=yes): 1 G3 21 LN- tamoxifen NA 66 1 PgR- NA 1 1 ER- He- 4.19452054794521
GSM1100134 0.65 NA endocrine? (0=no, 1=yes): 1 G3 25 LN- tamoxifen NA 59 1 PgR- NA 1 1 ER- He+ 3.07945205479452
GSM1100133 1.39 NA endocrine? (0=no, 1=yes): 1 G3 28 LN- CMFx6; Tamoxifen NA 47 1 PgR+ NA 1 1 ER+ He+ 2.12602739726027
GSM1100132 3.05 NA endocrine? (0=no, 1=yes): 1 G2 30 LN- tamoxifen NA 63 1 NA NA 1 1 ER+ He+ 3.44931506849315
GSM110013 4.33 not specified endocrine? (0=no, 1=yes): 1 G3 35 LN+ Tam+CMFx6 cycles 4.33 53 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ NA 4.33
GSM1100130 4.83 not specified endocrine? (0=no, 1=yes): NA G1 60 LN+ NA 4.83 59 not specified PgR+ invasive ductal carcinoma NA not specified ER+ He- 4.83
GSM1100129 4.38 not specified endocrine? (0=no, 1=yes): 1 G3 20 LN- tamoxifen 4.38 62 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.38
GSM1100128 2.67 not specified endocrine? (0=no, 1=yes): 1 G1 24 LN+ Tam+ACx4 cycles 2.67 43 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 2.67
GSM1100127 4.67 not specified endocrine? (0=no, 1=yes): 0 G1 25 LN- none 4.67 55 not specified NA invasive ductal carcinoma and papillary carcinoma not specified not specified NA NA 4.67
GSM1100126 0.83 not specified endocrine? (0=no, 1=yes): 1 G3 28 LN- tamoxifen 0.83 84 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 0.83
GSM1100125 2.00 1 endocrine? (0=no, 1=yes): 1 G3 40 LN+ Tam+AC 2.00 38 1 PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 2.00
GSM1100124 4.92 not specified endocrine? (0=no, 1=yes): 1 G3 25 LN+ tamoxifen 4.92 67 not specified PgR- invasive ductal carcinoma 1 not specified ER+ He+ 4.92
GSM1100123 5.17 not specified endocrine? (0=no, 1=yes): 1 G1 20 LN- tamoxifen 5.17 52 not specified PgR+ invasive lobular carcinoma 1 not specified ER+ He- 5.17
GSM1100122 3.83 1 endocrine? (0=no, 1=yes): 1 G3 16 LN+ Tam+ACx4 cycles 3.83 50 1 PgR+ invasive ductal carcinoma 1 not specified ER- He+ 5.75
GSM110012 5.21 not specified endocrine? (0=no, 1=yes): 1 G3 50 LN- tamoxifen 5.21 64 not specified PgR+ medullary carcinoma 1 not specified ER+ He+ 5.21
GSM1100120 4.54 not specified endocrine? (0=no, 1=yes): 0 G3 30 LN+ CAF 4.54 47 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.54
GSM1100119 5.58 not specified endocrine? (0=no, 1=yes): 1 G3 38 LN- Tam+ACx4 cycles 5.58 38 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 5.58
GSM1100118 5.92 not specified endocrine? (0=no, 1=yes): 1 G3 51 LN+ Tam+ACx4 cycles 5.92 58 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 5.92
GSM1100117 5.88 not specified endocrine? (0=no, 1=yes): 0 G3 21 LN- ACx4 cycles 5.88 47 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.88
GSM1100116 5.79 not specified endocrine? (0=no, 1=yes): 1 G3 18 LN- Tam+CMFx6 cycles 5.79 51 not specified PgR- invasive ductal carcinoma 1 not specified ER+ He- 5.79
GSM1100115 5.83 not specified endocrine? (0=no, 1=yes): 0 G3 35 LN- ACx4 cycles 5.83 48 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.83
GSM1100114 5.83 not specified endocrine? (0=no, 1=yes): 0 G3 25 LN- ACx4 cycles 5.83 46 not specified PgR- invasive ductal carcinoma 1 not specified ER- He- 5.83
GSM1100113 1.33 1 endocrine? (0=no, 1=yes): 0 G3 27 LN- ACx4 cycles 1.92 51 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.58
GSM1100112 6.17 not specified endocrine? (0=no, 1=yes): 1 G3 25 LN- Tam+CMFx6 cycles 6.17 36 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 6.17
GSM1100 5.83 not specified endocrine? (0=no, 1=yes): 0 G3 15 LN+ CAFx6 cycles 5.83 61 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.83
GSM1100110 5.71 not specified endocrine? (0=no, 1=yes): 0 G3 32 LN- ACx4 cycles 5.71 48 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.71
GSM1100109 5.88 not specified endocrine? (0=no, 1=yes): 0 G3 25 LN+ CMF 5.88 61 not specified PgR- invasive ductal carcinoma 1 not specified ER+ He- 5.88
GSM1100108 1.17 not specified endocrine? (0=no, 1=yes): 0 G3 20 LN- none 1.17 42 not specified PgR- medullary carcinoma not specified not specified ER- He- 6.50
GSM1100107 3.50 not specified endocrine? (0=no, 1=yes): 1 G1 40 LN- tamoxifen 3.50 77 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.33
GSM1100106 NA NA endocrine? (0=no, 1=yes): 1 G1 40 LN- tamoxifen NA 81 NA PgR+ papillary carcinoma 1 NA ER+ He- NA
GSM1100105 4.00 not specified endocrine? (0=no, 1=yes): NA G3 23 LN- NA 4.00 42 not specified PgR- invasive ductal carcinoma NA not specified ER- He+ 4.00
GSM1100104 2.29 1 endocrine? (0=no, 1=yes): 1 G3 36 LN- Tam+ACx4 cycles 2.29 38 1 PgR- invasive ductal carcinoma 1 not specified ER+ He+ 2.88
GSM1100103 0.79 1 endocrine? (0=no, 1=yes): 0 G3 30 LN+ ACx4 cycles 0.79 51 1 PgR- invasive ductal carcinoma 1 not specified ER- He+ 1.46
GSM1100102 5.58 not specified endocrine? (0=no, 1=yes): 1 G1 15 LN- Tam+CMFx6 cycles 5.58 60 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.79
GSM110010 6.29 not specified endocrine? (0=no, 1=yes): 1 G3 45 LN+ Tam+ACx4 cycles 6.29 52 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 6.29
GSM1100100 0.75 not specified endocrine? (0=no, 1=yes): 0 G3 35 LN- ACx4 cycles 0.75 48 not specified PgR- invasive ductal carcinoma 1 not specified ER- He- 0.75
GSM1100099 4.17 not specified endocrine? (0=no, 1=yes): 0 G3 22 LN- AC 4.17 42 not specified PgR- invasive ductal carcinoma 1 not specified ER- He- 4.25
GSM1100098 5.08 not specified endocrine? (0=no, 1=yes): 0 G3 30 LN+ ACx4 cycles 5.08 48 not specified PgR- invasive ductal carcinoma 1 not specified ER- He- 5.08
GSM1100097 4.38 not specified endocrine? (0=no, 1=yes): 0 G3 35 LN+ ACx8 cycles; taxol 4.38 34 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 4.38
GSM1100096 2.21 1 endocrine? (0=no, 1=yes): 0 G1 80 LN+ CAFx6 cycles 2.21 29 1 PgR+ invasive lobular carcinoma 1 1 ER+ He- 3.04
GSM1100095 3.13 not specified endocrine? (0=no, 1=yes): 1 G1 21 LN+ tamoxifen 3.13 86 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.38
GSM1100094 1.29 1 endocrine? (0=no, 1=yes): 0 G3 35 LN+ CAF 1.29 54 1 PgR- invasive ductal carcinoma 1 1 ER- He+ 1.38
GSM1100093 0.13 1 endocrine? (0=no, 1=yes): NA G3 22 LN+ NA 0.13 46 1 PgR- invasive ductal carcinoma NA 1 ER- He+ 0.38
GSM1100092 5.54 not specified endocrine? (0=no, 1=yes): 0 G3 40 LN- ACx4 cycles 5.54 41 not specified PgR- invasive ductal carcinoma 1 not specified ER- He- 5.54
GSM110009 1.96 1 endocrine? (0=no, 1=yes): 1 G3 40 LN+ tamoxifen 1.96 80 1 PgR+ invasive ductal carcinoma 1 not specified ER+ He- 1.96
GSM1100090 4.83 not specified endocrine? (0=no, 1=yes): 0 G3 20 LN+ CAF 4.83 45 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 4.83
GSM1100089 5.08 not specified endocrine? (0=no, 1=yes): 0 G3 30 LN- ACx4 cycles 5.08 64 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.08
GSM1100088 0.88 1 endocrine? (0=no, 1=yes): 0 G3 35 LN+ none 0.88 62 1 PgR- invasive ductal carcinoma not specified not specified ER- He+ 1.00
GSM1100087 0.00 1 endocrine? (0=no, 1=yes): 1 G3 25 LN+ Arimidex+CMFx2 cycles 0.00 62 1 PgR+ invasive ductal carcinoma 1 1 ER+ He+ 2.08
GSM1100086 1.96 not specified endocrine? (0=no, 1=yes): 0 G3 30 LN+ CAF 1.96 58 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 1.96
GSM1100085 5.25 not specified endocrine? (0=no, 1=yes): 0 G3 25 LN+ AC 5.25 45 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 5.29
GSM1100084 3.96 1 endocrine? (0=no, 1=yes): 0 G3 20 LN+ ACx4 cycles 3.96 54 1 PgR- invasive ductal carcinoma 1 1 ER- He+ 4.63
GSM1100083 4.00 not specified endocrine? (0=no, 1=yes): 0 G3 50 LN+ ACx4 cycles 4.00 44 not specified PgR- invasive ductal carcinoma 1 not specified ER- NA 4.00
GSM1100082 2.04 1 endocrine? (0=no, 1=yes): 1 G3 30 LN+ tamoxifen 2.04 74 1 PgR- invasive ductal carcinoma 1 1 ER+ He+ 2.25
GSM110008 4.00 not specified endocrine? (0=no, 1=yes): 0 G3 35 LN+ ACx4 cycles 4.00 52 not specified PgR- invasive lobular carcinoma 1 not specified ER- He+ 4.33
GSM1100080 1.00 not specified endocrine? (0=no, 1=yes): 0 G3 60 LN- ACx4 cycles 1.00 55 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.00
GSM1100079 0.13 not specified endocrine? (0=no, 1=yes): 1 G1 38 LN- tamoxifen NA 66 not specified PgR+ mucinous carcinoma 1 not specified ER+ He- 0.13
GSM1100078 4.88 not specified endocrine? (0=no, 1=yes): 0 G3 32 LN+ CAF 4.88 47 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.88
GSM1100077 4.46 not specified endocrine? (0=no, 1=yes): 1 G3 20 LN- tamoxifen 4.46 55 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 4.46
GSM1100076 5.46 not specified endocrine? (0=no, 1=yes): 1 G1 15 LN- tamoxifen;goserelin 5.46 45 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.46
GSM1100075 1.54 not specified endocrine? (0=no, 1=yes): 0 G3 40 LN- ACx4 cycles 1.54 34 not specified PgR- invasive ductal carcinoma 1 not specified ER- He+ 5.46
GSM1100074 5.00 not specified endocrine? (0=no, 1=yes): 0 G2 35 LN- ACx4 cycles 5.00 47 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.00
GSM1100073 5.33 not specified endocrine? (0=no, 1=yes): 1 G2 15 LN- tamoxifen 5.33 49 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.33
GSM1100072 5.58 not specified endocrine? (0=no, 1=yes): 1 G2 12 LN- tamoxifen 5.58 64 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.58
GSM110007 NA NA endocrine? (0=no, 1=yes): NA G2 17 LN- NA NA 66 NA PgR+ invasive ductal carcinoma NA not specified ER+ He+ 0.08
GSM1100070 4.00 not specified endocrine? (0=no, 1=yes): NA G2 40 LN+ NA 4.00 46 not specified PgR+ invasive ductal and lobular carcinoma NA not specified ER- He- 4.50
GSM1100069 4.83 not specified endocrine? (0=no, 1=yes): 1 G2 20 LN+ tamoxifen 4.83 73 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.92
GSM1100068 4.88 not specified endocrine? (0=no, 1=yes): 1 G2 15 LN- Tam+CMFx6 cycles 4.88 46 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.88
GSM1100067 4.50 not specified endocrine? (0=no, 1=yes): NA G2 30 LN+ NA 4.50 42 not specified PgR- invasive ductal carcinoma NA not specified ER+ He- 4.50
GSM1100066 1.67 1 endocrine? (0=no, 1=yes): 1 G2 60 LN+ Tam+CAFx2 cycles 1.67 46 1 PgR- invasive ductal carcinoma 1 1 ER+ He+ 1.75
GSM1100065 0.42 not specified endocrine? (0=no, 1=yes): 0 G2 24 LN+ none 0.42 44 not specified PgR+ invasive ductal carcinoma not specified not specified ER+ He+ 0.42
GSM1100064 4.92 not specified endocrine? (0=no, 1=yes): 1 G2 19 LN+ tamoxifen 4.92 55 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.92
GSM1100063 4.75 not specified endocrine? (0=no, 1=yes): 1 G2 21 LN- tamoxifen 4.75 57 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 4.75
GSM1100062 5.17 not specified endocrine? (0=no, 1=yes): 0 G2 23 LN+ CAF 5.17 40 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.17
GSM110006 4.67 not specified endocrine? (0=no, 1=yes): 0 G2 35 LN- CMF 4.67 44 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.67
GSM1100060 5.67 not specified endocrine? (0=no, 1=yes): 0 G2 30 LN+ CAF 5.67 46 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 5.67
GSM1100059 4.67 not specified endocrine? (0=no, 1=yes): 1 G2 40 LN- Tam+ACx4 cycles 4.67 35 not specified PgR+ invasive ductal carcinoma 1 not specified ER- He- 4.67
GSM1100058 0.67 1 endocrine? (0=no, 1=yes): 0 G2 15 LN- none 1.25 55 not specified PgR+ invasive ductal carcinoma not specified not specified ER+ He- 4.58
GSM1100057 2.83 1 endocrine? (0=no, 1=yes): 0 G2 25 LN- none 2.83 67 1 PgR- invasive ductal carcinoma not specified not specified ER- He+ 2.83
GSM1100056 0.67 1 endocrine? (0=no, 1=yes): 1 G2 40 LN+ tamoxifen 0.92 75 not specified PgR+ invasive ductal carcinoma 1 not specified ER- He+ 5.42
GSM1100055 0.04 1 endocrine? (0=no, 1=yes): 0 G2 15 LN- anastrozole;taxol 0.04 48 1 PgR- invasive lobular carcinoma 1 1 ER+ He- 3.08
GSM1100054 5.25 not specified endocrine? (0=no, 1=yes): 1 G2 23 LN+ Tam+CAFx6 cycles 5.25 49 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 5.25
GSM1100053 5.00 not specified endocrine? (0=no, 1=yes): 0 G2 25 LN+ CAF 5.00 69 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.00
GSM1100052 NA NA endocrine? (0=no, 1=yes): 1 G2 25 LN+ Tam+ACx8;taxol NA 51 NA PgR- invasive ductal carcinoma 1 NA ER+ He+ NA
GSM110005 6.33 not specified endocrine? (0=no, 1=yes): 1 G2 20 LN- Tam+CMFx6 cycles 6.33 60 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 6.33
GSM1100050 5.58 not specified endocrine? (0=no, 1=yes): 1 G2 35 LN- tamoxifen 5.58 77 not specified PgR- invasive ductal carcinoma 1 not specified ER+ He+ 5.58
GSM1100049 5.75 not specified endocrine? (0=no, 1=yes): 0 G2 22 LN+ CMF 5.75 53 not specified PgR+ invasive ductal carcinoma 1 not specified ER- He- 5.92
GSM1100048 5.83 not specified endocrine? (0=no, 1=yes): 0 G2 25 LN+ CAF 5.83 50 not specified PgR+ invasive ductal carcinoma 1 not specified ER- He- 5.83
GSM1100047 5.79 not specified endocrine? (0=no, 1=yes): 0 G2 18 LN- CMF 5.79 52 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 5.79
GSM1100046 6.00 not specified endocrine? (0=no, 1=yes): 1 G2 18 LN- tamoxifen 6.00 53 not specified PgR- invasive ductal carcinoma 1 not specified ER+ He- 6.00
GSM1100045 4.04 not specified endocrine? (0=no, 1=yes): 0 G2 15 LN- none 4.04 46 not specified PgR- invasive ductal carcinoma not specified not specified ER- He+ 4.08
GSM1100044 5.63 not specified endocrine? (0=no, 1=yes): NA G2 20 LN- NA 5.63 48 not specified PgR+ invasive ductal carcinoma NA not specified ER+ He+ 5.63
GSM1100043 2.00 1 endocrine? (0=no, 1=yes): 0 G2 60 LN+ ACx4 cycles 2.00 54 1 PgR- invasive ductal carcinoma 1 not specified ER- He+ 2.25
GSM1100042 6.25 not specified endocrine? (0=no, 1=yes): 1 G2 25 LN- tamoxifen 6.25 69 not specified PgR- invasive ductal carcinoma 1 not specified ER+ He+ 6.25
GSM110004 2.63 not specified endocrine? (0=no, 1=yes): 1 G2 25 LN- Tam+CMFx6 cycles 2.63 40 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He+ 2.63
GSM1100040 5.88 not specified endocrine? (0=no, 1=yes): 1 G2 35 LN- tamoxifen 5.88 69 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 6.04
GSM1100039 4.29 not specified endocrine? (0=no, 1=yes): 1 G2 30 LN- tamoxifen 4.29 69 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 4.29
GSM1100038 1.13 1 endocrine? (0=no, 1=yes): 0 G2 30 LN+ ACx4 cycles 1.13 62 1 PgR- invasive ductal carcinoma 1 not specified ER- He+ 1.13
GSM1100037 6.17 not specified endocrine? (0=no, 1=yes): 1 G2 20 LN- Tam+ACx4 cycles 6.17 41 not specified PgR+ invasive ductal carcinoma 1 not specified ER+ He- 6.17

Tags

  • breast
  • breast cancer
  • cancer
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use